The HIB Vaccine
Perfecting the Vaccine

-
Hib bacteria have a protective polysaccharide capsule (a sugar coating) called polyribosylribitol phosphate (PRP).
-
Our immune system has a hard time recognizing polysaccharides alone, especially in infants and young children, because:
-
Polysaccharides trigger a T-cell independent immune response.
-
This type of response is weak and does not create strong memory.
-
So, a vaccine made of just the Hib polysaccharide would not protect young children effectively.
1. The Problem: HIB VACCINE
2. The Solution: Conjugation
-
Scientists attach (conjugate) the Hib polysaccharide to a protein carrier—in this case, tetanus toxoid (a harmless form of the tetanus toxin).
-
Why tetanus toxoid?
-
Proteins are recognized by T-helper cells, which can amplify the immune response.
-
Using tetanus toxoid is safe and already known to be very effective at stimulating immunity.
-
3. How the Immune System Responds
​
-
Recognition: Immune cells recognize the conjugate vaccine.
-
The B cells bind the Hib polysaccharide.
-
The protein part (tetanus toxoid) is presented to T-helper cells.
-
Activation: T-helper cells provide signals that tell B cells to:
-
Make antibodies against the Hib polysaccharide.
-
Create memory B cells.
-
Protection: The body now has:
-
Antibodies that can attach to Hib bacteria if encountered in the future.
-
Immunological memory—so the immune system responds faster and stronger on actual exposure.

